Efficacy of gabapentin on pruritus induced by interleukin-2 (IL-2) treatment in patients with metastatic renal cell carcinoma and melanoma

被引：0

作者：

Lee, S. ^{[1
]}

Rusciano, V. ^{[1
]}

Dutcher, J. P. ^{[1
]}

机构：

[1] New York Med, Our Lady Mercy Med Ctr, Bronx, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3056

引用

页数：1

共 50 条

[1] Efficacy of gabapentin on pruritus induced by interleukin-2 (IL-2) treatment in patients with metastatic renal cell carcinoma and melanoma.
Rusciano, Valerie
Dutcher, Janice
ONCOLOGY NURSING FORUM, 2007, 34 (02) : 535 - 536
[2] Eosinophilia and pruritus with interleukin-2 treatment in patients with metastatic renal cell carcinoma
Lee, Sung Ho
Dasanu, Constantin
Dutcher, Janice
JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 639 - 639
[3] Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)
Huland, E
Heinzer, H
Huland, H
ANTICANCER RESEARCH, 1999, 19 (4A) : 2679 - 2683
[4] TREATMENT OF METASTATIC MELANOMA AND RENAL-CELL CARCINOMA WITH INTERLEUKIN-2
MANSON, LA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (17): : 1327 - 1327
[5] Novel Management of Pruritus in Patients Treated With IL-2 for Metastatic Renal Cell Carcinoma and Malignant Melanoma
Lee, Sung Ho
Baig, Mahadi
Rusciano, Valerie
Dutcher, Janice P.
JOURNAL OF IMMUNOTHERAPY, 2010, 33 (09) : 1010 - 1013
[6] INTERLEUKIN-2 (IL-2) IN THE MANAGEMENT OF PATIENTS WITH RENAL-CELL CARCINOMA
HEMSTREET, GP
WHITEHEAD, RP
OWENSCHAUB, LB
DEBAULT, LE
JOURNAL OF UROLOGY, 1987, 137 (04): : A222 - A222
[7] The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma
Hughes, Tasha
Klairmont, Matthew
Broucek, Joseph
Iodice, Gail
Basu, Sanjib
Kaufman, Howard L.
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (04) : 459 - 465
[8] The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma
Tasha Hughes
Matthew Klairmont
Joseph Broucek
Gail Iodice
Sanjib Basu
Howard L. Kaufman
Cancer Immunology, Immunotherapy, 2015, 64 : 459 - 465
[9] Disparities in the treatment of patients with IL-2 for metastatic renal cell carcinoma
Saigal, Christopher S.
Deibert, Christopher M.
Lai, Julie
Schonlau, Matthias
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (03) : 308 - 313
[10] High dose IL-2 in the treatment of metastatic melanoma and metastatic renal cell carcinoma.
Woodrum, T
ONCOLOGY NURSING FORUM, 2004, 31 (02) : 404 - 404

← 1 2 3 4 5 →